← FDA Drug Approvals (Drugs@FDA)
EBGLYSS
BLA · Biologics License Application · Sponsor: ELI LILLY AND CO · Approved 2024-09-13
Drug application
- FDA Application #
BLA761306- Application type
- Biologics License Application
- Brand name
- EBGLYSS
- Generic name
- LEBRIKIZUMAB-LBKZ
- Active ingredients
- LEBRIKIZUMAB-LBKZ
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ELI LILLY AND CO
- Manufacturer
- Eli Lilly and Company
- First approval
- 2024-09-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown